Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Xiaojun Dai
Observed names:
Dai, Xiaojun,
X G Dai
Institutions:
Nanjing University of Chinese Medicine,
Chongqing Medical University
Observed institutions:
Nanjing University of Chinese Medicine,
State Administration of Traditional Chinese Medicine of the People's Republic of China,
Chenzhou First People's Hospital,
Southern Medical University,
Yangzhou University,
Chongqing Medical University
show all 6
ORCID:
0000-0003-2647-4725
Observed ORCID:
0000-0003-2647-4725
OpenAlex ID:
A5037174934
Traditional Banxia Xiexin decoction inhibits invasion, metastasis, and epithelial mesenchymal transition in gastric cancer by reducing lncRNA TUC338 expression
2023
·
Xiaojun Dai
, Yanwei Yu
, et al.
·
Heliyon
·
16
Exploring changes in metabolites and fecal microbiota of advanced gastric cancer based on plasma metabolomics and 16S rDNA sequencing
2025
·
Xinyi Feng
, Yu Zhang
, et al.
·
Heliyon
·
13
Implementation Challenges of Remote Cancer Symptom Management With Electronic Patient‑Reported Outcomes in China’s Primary Health Care Settings: Qualitative Study
2025
·
Min Li
, Jingyu Zhang
, et al.
·
Journal of Medical Internet Research
·
4
[Influence of family with sequence similarity 134, member B-mediated reticulophagy on lipopolysaccharide-induced apoptosis of mouse dendritic cells].
2023
·
Y Duan
, R Q Yao
, et al.
·
PubMed Central
·
1
PDF
Prioritizing implementation strategies of electronic patient-reported outcome in cancer management in primary health care: A best–worst scaling study among stakeholders
2026
·
Changjin Wu
, Jingyu Zhang
, et al.
·
Digital Health
Show more works
View as search
Works count:
8
Citation count:
34
H-index:
3
I10-index:
2
Year
Topic
Type